Drug Type Small molecule drug |
Synonyms Pleneva, BGC 200134 |
Target |
Action modulators |
Mechanism TGF-β1 modulators(Transforming growth factor beta 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis, Relapsing-Remitting | Phase 2 | France | 21 Oct 2009 |





